Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A group of “immunological nonresponders” wants the FDA to grant them orphan disease status.
The new federal initiative will work with existing research programs in eight cities.
Because the scientists use fetal tissue.
The study hopes to understand why Black women, who are at higher risk for HIV, are not likely to take PrEP.
A Campbell Foundation grant funds HIV-related research into lymph node fibrosis.
Watch Gregg Gonsalves explain how his work affects public health, human rights and health inequities. [VIDEO]
Two of them represent the host cities: San Francisco and Oakland. The third is an international scientist.
More than 300 organizations call for more funding for the National Institutes of Health.
The Campbell Foundation’s latest grant funds research into the RV144 trial in Thailand, which showed 31 percent protection against HIV.
The goal is an inexpensive point-of-care test that quickly determines an individual’s best treatment options.
Take a survey on HIV cure research.
It’s just one episode of “HIV Matters,” a (free!) podcast series from the University of North Carolina’s Department of Medicine.
Robert R. Redfield, MD, is a longtime HIV researcher. But he’s also controversial.
Scientists tested the effects of the broadly neutralizing antibody PGT121 and the immune-stimulating agent GS-9620 in monkeys.
An estimated 7,760 HIV-positive U.S. residents were diagnosed with cancer in 2010.
Merck’s investigational antiretroviral could one day be dosed only weekly among HIV-negative humans.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.